Your browser doesn't support javascript.
loading
Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist.
Zhou, Yan; Freeman, Kevin; Setola, Vincent; Cao, Danni; Kaski, Shane; Kreek, Mary Jeanne; Liu-Chen, Lee-Yuan.
Afiliación
  • Zhou Y; Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY, USA.
  • Freeman K; Division of Neurobiology and Behavior Research, Department of Psychiatry and Human Behavior, The University of Mississippi Medical Center, Jackson, MS, USA.
  • Setola V; Departments of Neuroscience, and Behavioral Medicine and Psychiatry, West Virginia University School of Medicine, Morgantown, WV, USA.
  • Cao D; Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
  • Kaski S; Departments of Neuroscience, and Behavioral Medicine and Psychiatry, West Virginia University School of Medicine, Morgantown, WV, USA.
  • Kreek MJ; Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY, USA.
  • Liu-Chen LY; Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA. lliuche@temple.edu.
Handb Exp Pharmacol ; 271: 137-162, 2022.
Article en En | MEDLINE | ID: mdl-33834276

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Espiro / Morfinanos Límite: Animals / Humans Idioma: En Revista: Handb Exp Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Espiro / Morfinanos Límite: Animals / Humans Idioma: En Revista: Handb Exp Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos